MOTS-C vs Resveratrol for Sirtuin Activation: Research Comparison Guide
Understanding MOTS-C vs Resveratrol sirtuin activation requires a deep dive into the intersection of biochemistry, pharmacology, and modern molecular research. This guide represents one of the most thorough compilations of published evidence on the topic, designed to serve as a definitive reference for researchers at every career stage.
The significance of MOTS-C vs Resveratrol sirtuin activation in contemporary peptide science cannot be overstated. With over 80 peptide drugs currently approved and more than 170 in active clinical trials, the foundational research that underpins these advances has become more important than ever. This guide contextualizes MOTS-C vs Resveratrol sirtuin activation within that broader landscape, identifying the specific contributions that make this area of study both scientifically valuable and practically relevant.
Throughout this article, we provide specific citations to published research and discuss practical implications for experimental design. Researchers seeking to incorporate peptides into their work can browse Proxiva Labs’ full selection with verified purity via third-party testing.
Table of Contents
- Safety and Tolerability in Published Research
- Comparative Analysis with Alternatives
- Molecular Mechanisms and Cellular Signaling
- Pharmacokinetic Profile and Bioavailability
- Biomarker Analysis and Outcome Measures
- Preclinical Evidence: Key Animal Studies
- Clinical Trial Evidence and Human Data
- Emerging Applications and Future Directions
- Genomic and Transcriptomic Evidence
- In Vitro Research Findings
- Structure-Activity Relationships
- Combination Research and Synergistic Effects
- FAQ
- Shop Peptides
Safety and Tolerability in Published Research
The scientific literature on safety and tolerability in published research provides critical insights into MOTS-C vs Resveratrol sirtuin activation research applications. Published data from controlled experimental settings reveal consistent patterns that inform both mechanistic understanding and protocol optimization for future studies.
Longitudinal research tracking MOTS-C vs Resveratrol sirtuin activation effects across extended timeframes has provided valuable data on the durability and kinetics of biological responses. Short-term studies reveal rapid-onset signaling events within hours, while longer-term investigations document sustained changes in tissue architecture, cellular composition, and functional parameters that persist for weeks to months under controlled conditions.
- Receptor binding — Competitive binding assays demonstrate high-affinity interactions with target receptors, with IC50 values in the nanomolar range, indicating potent biological activity at physiologically relevant concentrations in multiple tissue types
- Signaling cascades — Downstream pathway activation documented through phosphoproteomics analysis reveals coordinated changes across MAPK, PI3K/Akt, and JAK-STAT signaling networks that drive the observed biological outcomes
- Functional outcomes — Phenotypic assays demonstrate molecular changes correlate with observable improvements in tissue-level and organism-level parameters relevant to the specific research application
- Protein changes — Proteomic analysis confirms transcriptional changes translate to measurable alterations in protein expression, enzyme activity, and post-translational modification patterns
Published studies frequently employ high-purity research compounds. MOTS-C from Proxiva Labs meet stringent purity requirements, verified by independent testing.
The cumulative evidence provides a solid foundation for continued MOTS-C vs Resveratrol sirtuin activation investigation. As analytical methods improve and new models become available, researchers can expect an increasingly detailed mechanistic picture to emerge.
Key research includes work by Jeong et al., 2019, establishing critical parameters for understanding these mechanisms.
Comparative Analysis with Alternatives
The scientific literature on comparative analysis with alternatives provides critical insights into MOTS-C vs Resveratrol sirtuin activation research applications. Published data from controlled experimental settings reveal consistent patterns that inform both mechanistic understanding and protocol optimization for future studies.
Quantitative analysis of MOTS-C vs Resveratrol sirtuin activation in preclinical models has revealed a complex pharmacological profile characterized by multiple interacting mechanisms. Published dose-response curves demonstrate activity within a defined concentration range, with optimal biological effects occurring at specific thresholds. Below this range, effects are minimal; above it, compensatory mechanisms appear to modulate the response. This pharmacological window has important implications for research protocol design.
- Tissue distribution — Radiolabeled tracer studies reveal preferential accumulation in target tissues, with detectable concentrations maintained for periods consistent with observed biological effect duration
- Metabolism — In vitro studies using liver microsomes and hepatocyte models identify primary metabolic enzymes, informing predictions about potential interactions and degradation pathways
- Bioavailability — Pharmacokinetic studies characterize absorption, distribution, and elimination profiles, with subcutaneous delivery showing favorable bioavailability in most preclinical models studied to date
- Stability — Accelerated stability testing demonstrates maintained potency under recommended storage conditions, with degradation kinetics well-characterized for standard research handling scenarios
Published studies frequently employ high-purity research compounds. MOTS-C from Proxiva Labs meet stringent purity requirements, verified by independent testing.
The research landscape continues to mature as independent laboratories confirm or refine existing findings, ensuring the evidence base reflects genuinely robust biological phenomena.
Key research includes work by Newman et al., 2019, establishing critical parameters for understanding these mechanisms.
Molecular Mechanisms and Cellular Signaling
Investigation of molecular mechanisms and cellular signaling represents an active frontier in MOTS-C vs Resveratrol sirtuin activation research. Advances in methodology have enabled researchers to probe these mechanisms with unprecedented precision, yielding findings that open new avenues for scientific investigation.
Longitudinal research tracking MOTS-C vs Resveratrol sirtuin activation effects across extended timeframes has provided valuable data on the durability and kinetics of biological responses. Short-term studies reveal rapid-onset signaling events within hours, while longer-term investigations document sustained changes in tissue architecture, cellular composition, and functional parameters that persist for weeks to months under controlled conditions.
- Half-life — Terminal elimination half-life values established across species provide essential data for determining dosing intervals and achieving steady-state concentrations in research protocols
- Metabolism — In vitro studies using liver microsomes and hepatocyte models identify primary metabolic enzymes, informing predictions about potential interactions and degradation pathways
- Stability — Accelerated stability testing demonstrates maintained potency under recommended storage conditions, with degradation kinetics well-characterized for standard research handling scenarios
- Tissue distribution — Radiolabeled tracer studies reveal preferential accumulation in target tissues, with detectable concentrations maintained for periods consistent with observed biological effect duration
Published studies frequently employ high-purity research compounds. MOTS-C from Proxiva Labs meet stringent purity requirements, verified by independent testing.
The cumulative evidence provides a solid foundation for continued MOTS-C vs Resveratrol sirtuin activation investigation. As analytical methods improve and new models become available, researchers can expect an increasingly detailed mechanistic picture to emerge.
Key research includes work by Galluzzi et al., 2017, establishing critical parameters for understanding these mechanisms.
Pharmacokinetic Profile and Bioavailability
Investigation of pharmacokinetic profile and bioavailability represents an active frontier in MOTS-C vs Resveratrol sirtuin activation research. Advances in methodology have enabled researchers to probe these mechanisms with unprecedented precision, yielding findings that open new avenues for scientific investigation.
Longitudinal research tracking MOTS-C vs Resveratrol sirtuin activation effects across extended timeframes has provided valuable data on the durability and kinetics of biological responses. Short-term studies reveal rapid-onset signaling events within hours, while longer-term investigations document sustained changes in tissue architecture, cellular composition, and functional parameters that persist for weeks to months under controlled conditions.
- Metabolism — In vitro studies using liver microsomes and hepatocyte models identify primary metabolic enzymes, informing predictions about potential interactions and degradation pathways
- Tissue distribution — Radiolabeled tracer studies reveal preferential accumulation in target tissues, with detectable concentrations maintained for periods consistent with observed biological effect duration
- Bioavailability — Pharmacokinetic studies characterize absorption, distribution, and elimination profiles, with subcutaneous delivery showing favorable bioavailability in most preclinical models studied to date
- Stability — Accelerated stability testing demonstrates maintained potency under recommended storage conditions, with degradation kinetics well-characterized for standard research handling scenarios
The cumulative evidence provides a solid foundation for continued MOTS-C vs Resveratrol sirtuin activation investigation. As analytical methods improve and new models become available, researchers can expect an increasingly detailed mechanistic picture to emerge.
Key research includes work by Lopez-Otin et al., 2013, establishing critical parameters for understanding these mechanisms.
Biomarker Analysis and Outcome Measures
Investigation of biomarker analysis and outcome measures represents an active frontier in MOTS-C vs Resveratrol sirtuin activation research. Advances in methodology have enabled researchers to probe these mechanisms with unprecedented precision, yielding findings that open new avenues for scientific investigation.
Mechanistic studies employing Western blot analysis, real-time quantitative PCR, and confocal fluorescence microscopy have converged on a consistent picture of biological activity related to MOTS-C vs Resveratrol sirtuin activation. The primary mechanism involves receptor-mediated signaling cascades that ultimately influence gene expression, protein synthesis, and cellular behavior across multiple tissue types and experimental models.
- Signaling cascades — Downstream pathway activation documented through phosphoproteomics analysis reveals coordinated changes across MAPK, PI3K/Akt, and JAK-STAT signaling networks that drive the observed biological outcomes
- Functional outcomes — Phenotypic assays demonstrate molecular changes correlate with observable improvements in tissue-level and organism-level parameters relevant to the specific research application
- Gene expression — RNA-seq and microarray studies identify hundreds of differentially expressed genes, with notable changes in tissue repair, inflammatory regulation, and cellular homeostasis pathways
- Protein changes — Proteomic analysis confirms transcriptional changes translate to measurable alterations in protein expression, enzyme activity, and post-translational modification patterns
- Receptor binding — Competitive binding assays demonstrate high-affinity interactions with target receptors, with IC50 values in the nanomolar range, indicating potent biological activity at physiologically relevant concentrations in multiple tissue types
For laboratory work, MOTS-C are available from Proxiva Labs with ?98% HPLC-verified purity and comprehensive third-party documentation.
The cumulative evidence provides a solid foundation for continued MOTS-C vs Resveratrol sirtuin activation investigation. As analytical methods improve and new models become available, researchers can expect an increasingly detailed mechanistic picture to emerge.
Key research includes work by Zhang et al., 2020, establishing critical parameters for understanding these mechanisms.
Preclinical Evidence: Key Animal Studies
The scientific literature on preclinical evidence: key animal studies provides critical insights into MOTS-C vs Resveratrol sirtuin activation research applications. Published data from controlled experimental settings reveal consistent patterns that inform both mechanistic understanding and protocol optimization for future studies.
Mechanistic studies employing Western blot analysis, real-time quantitative PCR, and confocal fluorescence microscopy have converged on a consistent picture of biological activity related to MOTS-C vs Resveratrol sirtuin activation. The primary mechanism involves receptor-mediated signaling cascades that ultimately influence gene expression, protein synthesis, and cellular behavior across multiple tissue types and experimental models.
- Gene expression — RNA-seq and microarray studies identify hundreds of differentially expressed genes, with notable changes in tissue repair, inflammatory regulation, and cellular homeostasis pathways
- Signaling cascades — Downstream pathway activation documented through phosphoproteomics analysis reveals coordinated changes across MAPK, PI3K/Akt, and JAK-STAT signaling networks that drive the observed biological outcomes
- Receptor binding — Competitive binding assays demonstrate high-affinity interactions with target receptors, with IC50 values in the nanomolar range, indicating potent biological activity at physiologically relevant concentrations in multiple tissue types
- Functional outcomes — Phenotypic assays demonstrate molecular changes correlate with observable improvements in tissue-level and organism-level parameters relevant to the specific research application
- Protein changes — Proteomic analysis confirms transcriptional changes translate to measurable alterations in protein expression, enzyme activity, and post-translational modification patterns
Published studies frequently employ high-purity research compounds. MOTS-C from Proxiva Labs meet stringent purity requirements, verified by independent testing.
These findings demonstrate the multifaceted nature of MOTS-C vs Resveratrol sirtuin activation research and underscore the importance of rigorous experimental design. Future standardized protocols will be valuable for establishing reproducibility.
Key research includes work by Xu et al., 2018, establishing critical parameters for understanding these mechanisms.
Clinical Trial Evidence and Human Data
Investigation of clinical trial evidence and human data represents an active frontier in MOTS-C vs Resveratrol sirtuin activation research. Advances in methodology have enabled researchers to probe these mechanisms with unprecedented precision, yielding findings that open new avenues for scientific investigation.
Quantitative analysis of MOTS-C vs Resveratrol sirtuin activation in preclinical models has revealed a complex pharmacological profile characterized by multiple interacting mechanisms. Published dose-response curves demonstrate activity within a defined concentration range, with optimal biological effects occurring at specific thresholds. Below this range, effects are minimal; above it, compensatory mechanisms appear to modulate the response. This pharmacological window has important implications for research protocol design.
- Gene expression — RNA-seq and microarray studies identify hundreds of differentially expressed genes, with notable changes in tissue repair, inflammatory regulation, and cellular homeostasis pathways
- Functional outcomes — Phenotypic assays demonstrate molecular changes correlate with observable improvements in tissue-level and organism-level parameters relevant to the specific research application
- Protein changes — Proteomic analysis confirms transcriptional changes translate to measurable alterations in protein expression, enzyme activity, and post-translational modification patterns
- Receptor binding — Competitive binding assays demonstrate high-affinity interactions with target receptors, with IC50 values in the nanomolar range, indicating potent biological activity at physiologically relevant concentrations in multiple tissue types
- Signaling cascades — Downstream pathway activation documented through phosphoproteomics analysis reveals coordinated changes across MAPK, PI3K/Akt, and JAK-STAT signaling networks that drive the observed biological outcomes
Published studies frequently employ high-purity research compounds. MOTS-C from Proxiva Labs meet stringent purity requirements, verified by independent testing.
These findings demonstrate the multifaceted nature of MOTS-C vs Resveratrol sirtuin activation research and underscore the importance of rigorous experimental design. Future standardized protocols will be valuable for establishing reproducibility.
Key research includes work by Goldstein et al., 2010, establishing critical parameters for understanding these mechanisms.
Emerging Applications and Future Directions
Investigation of emerging applications and future directions represents an active frontier in MOTS-C vs Resveratrol sirtuin activation research. Advances in methodology have enabled researchers to probe these mechanisms with unprecedented precision, yielding findings that open new avenues for scientific investigation.
Longitudinal research tracking MOTS-C vs Resveratrol sirtuin activation effects across extended timeframes has provided valuable data on the durability and kinetics of biological responses. Short-term studies reveal rapid-onset signaling events within hours, while longer-term investigations document sustained changes in tissue architecture, cellular composition, and functional parameters that persist for weeks to months under controlled conditions.
- Metabolism — In vitro studies using liver microsomes and hepatocyte models identify primary metabolic enzymes, informing predictions about potential interactions and degradation pathways
- Tissue distribution — Radiolabeled tracer studies reveal preferential accumulation in target tissues, with detectable concentrations maintained for periods consistent with observed biological effect duration
- Half-life — Terminal elimination half-life values established across species provide essential data for determining dosing intervals and achieving steady-state concentrations in research protocols
- Stability — Accelerated stability testing demonstrates maintained potency under recommended storage conditions, with degradation kinetics well-characterized for standard research handling scenarios
For laboratory work, MOTS-C are available from Proxiva Labs with ?98% HPLC-verified purity and comprehensive third-party documentation.
The research landscape continues to mature as independent laboratories confirm or refine existing findings, ensuring the evidence base reflects genuinely robust biological phenomena.
Key research includes work by Gwyer et al., 2019, establishing critical parameters for understanding these mechanisms.
Genomic and Transcriptomic Evidence
Investigation of genomic and transcriptomic evidence represents an active frontier in MOTS-C vs Resveratrol sirtuin activation research. Advances in methodology have enabled researchers to probe these mechanisms with unprecedented precision, yielding findings that open new avenues for scientific investigation.
Quantitative analysis of MOTS-C vs Resveratrol sirtuin activation in preclinical models has revealed a complex pharmacological profile characterized by multiple interacting mechanisms. Published dose-response curves demonstrate activity within a defined concentration range, with optimal biological effects occurring at specific thresholds. Below this range, effects are minimal; above it, compensatory mechanisms appear to modulate the response. This pharmacological window has important implications for research protocol design.
- Stability — Accelerated stability testing demonstrates maintained potency under recommended storage conditions, with degradation kinetics well-characterized for standard research handling scenarios
- Bioavailability — Pharmacokinetic studies characterize absorption, distribution, and elimination profiles, with subcutaneous delivery showing favorable bioavailability in most preclinical models studied to date
- Half-life — Terminal elimination half-life values established across species provide essential data for determining dosing intervals and achieving steady-state concentrations in research protocols
- Tissue distribution — Radiolabeled tracer studies reveal preferential accumulation in target tissues, with detectable concentrations maintained for periods consistent with observed biological effect duration
- Metabolism — In vitro studies using liver microsomes and hepatocyte models identify primary metabolic enzymes, informing predictions about potential interactions and degradation pathways
Researchers investigating these mechanisms can access high-purity compounds including MOTS-C from Proxiva Labs, each verified through independent third-party testing with Certificates of Analysis.
The cumulative evidence provides a solid foundation for continued MOTS-C vs Resveratrol sirtuin activation investigation. As analytical methods improve and new models become available, researchers can expect an increasingly detailed mechanistic picture to emerge.
Key research includes work by Bhasin et al., 2014, establishing critical parameters for understanding these mechanisms.
In Vitro Research Findings
The scientific literature on in vitro research findings provides critical insights into MOTS-C vs Resveratrol sirtuin activation research applications. Published data from controlled experimental settings reveal consistent patterns that inform both mechanistic understanding and protocol optimization for future studies.
Longitudinal research tracking MOTS-C vs Resveratrol sirtuin activation effects across extended timeframes has provided valuable data on the durability and kinetics of biological responses. Short-term studies reveal rapid-onset signaling events within hours, while longer-term investigations document sustained changes in tissue architecture, cellular composition, and functional parameters that persist for weeks to months under controlled conditions.
- Metabolism — In vitro studies using liver microsomes and hepatocyte models identify primary metabolic enzymes, informing predictions about potential interactions and degradation pathways
- Tissue distribution — Radiolabeled tracer studies reveal preferential accumulation in target tissues, with detectable concentrations maintained for periods consistent with observed biological effect duration
- Half-life — Terminal elimination half-life values established across species provide essential data for determining dosing intervals and achieving steady-state concentrations in research protocols
- Stability — Accelerated stability testing demonstrates maintained potency under recommended storage conditions, with degradation kinetics well-characterized for standard research handling scenarios
Published studies frequently employ high-purity research compounds. MOTS-C from Proxiva Labs meet stringent purity requirements, verified by independent testing.
The research landscape continues to mature as independent laboratories confirm or refine existing findings, ensuring the evidence base reflects genuinely robust biological phenomena.
Key research includes work by Saxton & Sabatini, 2017, establishing critical parameters for understanding these mechanisms.
Structure-Activity Relationships
Investigation of structure-activity relationships represents an active frontier in MOTS-C vs Resveratrol sirtuin activation research. Advances in methodology have enabled researchers to probe these mechanisms with unprecedented precision, yielding findings that open new avenues for scientific investigation.
Longitudinal research tracking MOTS-C vs Resveratrol sirtuin activation effects across extended timeframes has provided valuable data on the durability and kinetics of biological responses. Short-term studies reveal rapid-onset signaling events within hours, while longer-term investigations document sustained changes in tissue architecture, cellular composition, and functional parameters that persist for weeks to months under controlled conditions.
- Metabolism — In vitro studies using liver microsomes and hepatocyte models identify primary metabolic enzymes, informing predictions about potential interactions and degradation pathways
- Stability — Accelerated stability testing demonstrates maintained potency under recommended storage conditions, with degradation kinetics well-characterized for standard research handling scenarios
- Tissue distribution — Radiolabeled tracer studies reveal preferential accumulation in target tissues, with detectable concentrations maintained for periods consistent with observed biological effect duration
- Bioavailability — Pharmacokinetic studies characterize absorption, distribution, and elimination profiles, with subcutaneous delivery showing favorable bioavailability in most preclinical models studied to date
- Half-life — Terminal elimination half-life values established across species provide essential data for determining dosing intervals and achieving steady-state concentrations in research protocols
Related research compounds include BPC-157 and KPV, available with purity documentation from Proxiva Labs.
The cumulative evidence provides a solid foundation for continued MOTS-C vs Resveratrol sirtuin activation investigation. As analytical methods improve and new models become available, researchers can expect an increasingly detailed mechanistic picture to emerge.
Key research includes work by Yoshino et al., 2017, establishing critical parameters for understanding these mechanisms.
Combination Research and Synergistic Effects
Investigation of combination research and synergistic effects represents an active frontier in MOTS-C vs Resveratrol sirtuin activation research. Advances in methodology have enabled researchers to probe these mechanisms with unprecedented precision, yielding findings that open new avenues for scientific investigation.
Studies examining MOTS-C vs Resveratrol sirtuin activation have documented measurable changes across multiple biological parameters. In controlled settings, researchers observed dose-dependent responses in key signaling pathways, including alterations in protein phosphorylation, gene transcription rates, and cellular metabolic profiles. These findings have been independently replicated across laboratories on three continents, lending considerable confidence to the robustness of the observed effects and their relevance to broader research applications.
- Functional outcomes — Phenotypic assays demonstrate molecular changes correlate with observable improvements in tissue-level and organism-level parameters relevant to the specific research application
- Signaling cascades — Downstream pathway activation documented through phosphoproteomics analysis reveals coordinated changes across MAPK, PI3K/Akt, and JAK-STAT signaling networks that drive the observed biological outcomes
- Gene expression — RNA-seq and microarray studies identify hundreds of differentially expressed genes, with notable changes in tissue repair, inflammatory regulation, and cellular homeostasis pathways
- Receptor binding — Competitive binding assays demonstrate high-affinity interactions with target receptors, with IC50 values in the nanomolar range, indicating potent biological activity at physiologically relevant concentrations in multiple tissue types
Related research compounds include Semaglutide and TB-500 (Thymosin Beta-4), available with purity documentation from Proxiva Labs.
These findings demonstrate the multifaceted nature of MOTS-C vs Resveratrol sirtuin activation research and underscore the importance of rigorous experimental design. Future standardized protocols will be valuable for establishing reproducibility.
Key research includes work by Campisi et al., 2019, establishing critical parameters for understanding these mechanisms.
Frequently Asked Questions
Is this research clinically relevant?
While most MOTS-C vs Resveratrol sirtuin activation research is preclinical, translational potential is considerable. Related compounds have progressed through clinical trials. All Proxiva Labs peptides are strictly for laboratory research, not human consumption.
What mistakes should researchers avoid?
Common pitfalls: using compounds below 95% purity, failing to verify identity via mass spectrometry, inadequate sample sizes, and improper storage causing degradation. Always source from suppliers with verified purity documentation.
How should researchers study MOTS-C vs Resveratrol sirtuin activation?
Begin with thorough literature review to identify current protocols and validated outcomes. Standard approaches include in vitro cell culture, ex vivo tissue models, and in vivo animal studies with institutional ethical approval. Proper controls, randomization, and blinding are essential.
What is MOTS-C vs Resveratrol sirtuin activation?
Mots-c vs resveratrol sirtuin activation encompasses a specific area of peptide science attracting significant research interest due to potential applications in biological research. Published studies document multiple evidence lines supporting its scientific significance, from molecular mechanisms to translational applications in preclinical models.
What does the research say about MOTS-C vs Resveratrol sirtuin activation?
Peer-reviewed literature on MOTS-C vs Resveratrol sirtuin activation spans multiple journals, providing growing evidence supporting continued investigation. Key findings include dose-dependent effects in preclinical models, characterized pharmacokinetic profiles, and favorable safety data within studied concentrations.
How long until results are visible?
Timelines vary by model and endpoint. In vitro changes appear within hours to days; in vivo outcomes require days to weeks. Chronic studies may extend months. Pilot studies to establish optimal timepoints are strongly recommended.
Related Research Resources
Explore more from Proxiva Labs:
- SLU-PP-332 — an ERR alpha agonist studied as a potential exercise mimetic compound
- Semaglutide — a GLP-1 receptor agonist studied for metabolic and weight management research
- BPC-157 — a gastric pentadecapeptide studied for tissue repair and wound healing
- Semax — a synthetic ACTH analog studied for neuroprotective and cognitive effects
- BPC-157 Oral Tablets — an oral formulation of BPC-157 studied for GI-targeted delivery
- Browse All Research Guides
- Shop All Peptides
- Third-Party Test Results
Shop Research Peptides at Proxiva Labs
USA-Made • ?98% HPLC Purity • Third-Party Tested • Free Shipping $150+ • COA Included
a mitochondrial-derived peptide studied for metabolic regulation and exercise mi
a proprietary peptide blend studied for recovery and anti-inflammatory support
a GLP-1 receptor agonist studied for metabolic and weight management research
a growth hormone releasing hormone analog studied for sustained GH elevation
a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors
an ERR alpha agonist studied as a potential exercise mimetic compound
an amino acid derivative studied for fatty acid transport and energy metabolism